We are the International AIDS Society
We convene, educate and advocate for a world in which HIV no longer presents a threat to public health and individual well-being.Learn more
This World AIDS Day, the IAS calls on all stakeholders to put communities first!
The IAS unites the global HIV response because progress happens when science, policy and activism come together. Here’s how we do this:
The 25th International AIDS Conference
AIDS 2024, the 25th International AIDS Conference, will take place in Munich, Germany, and virtually from 22 to 26 July 2024 and is expected to bring together some 18,000 participants from around the world.View details
ICASA satellite: The future of HIV testing in eastern and southern Africa – how to realize the potential of HIV self-testing
The context of HIV testing is changing in eastern and southern Africa as countries approach the 95-95-95 targets. Against this background, HIV testing is evolving and needs to reach clients across the prevention and treatment cascade. HIV self-testing (HIVST), a critical component and tool in the future of HIV testing, is the focus of an ICASA 2023 session, organized by IAS – the International AIDS Society – the Bill & Melinda Gates Foundation and ICAP at Columbia University.View details
ICASA satellite: Global initiatives to eliminate HIV-related stigma and discrimination
To end AIDS as a public health threat by 2030, it is critical to address HIV-related stigma and discrimination. In this session, the Global Network of People Living with HIV (GNP+) and IAS – the International AIDS Society – will share updates and findings from global initiatives to eliminate HIV-related stigma and discrimination. The session will start with sharing the first Global Report on the People Living with HIV (PLHIV) Stigma Index, with data from 25 countries which implemented the Stigma Index 2.0 between 2020 and 2023.View details
ICASA 2023 Satellite: Shaping the future: Unveiling Africa's role in HIV vaccine research and the dynamics of domestic funding
With over 25 million people living with HIV, Africa has the highest burden of the pandemic. However, research conducted in Africa on HIV vaccines is often underrepresented in the global scientific literature, which can lead to missed opportunities for discovery and innovation.
Increased domestic funding for HIV prevention-related research can help support the development of local research capacity and promote innovation, as well as create jobs, attract investment and promote scientific and technological development.
Sign up to receive our newsletter. Stay updated on our efforts and impact and learn how to make a difference.
Meet our members
The IAS at a glance
We unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all people living with and affected by HIV. Here are some numbers that show how we do that.
IAS change makers. Carefully selected HIV researchers, advocates, healthcare providers and others we educate to drive an evidence-based HIV response that puts people first.
IAS Members worldwide. We convene people from diverse backgrounds to drive a shared vision of a world in which HIV is no longer a threat to public health and individual well-being.
Scientific studies shared via our conferences and JIAS in 2020/21. We advocate for evidence-based progress to improve the lives of people living with and affected by HIV.